首页 > 市场调查报告书 > 医疗设备

病患监测血糖监测

市场调查报告书

商品编码

1424325

糖尿病监测设备市场：依产品类型、按适应症、依最终用户、按地区

Diabetes Monitoring Devices Market, By Product Type, By Indication, By End User, By Geography

出版日期: 2024年01月04日 | 出版商:

Coherent Market Insights | 英文 170 Pages | 商品交期: 2-3个工作天内

价格

简介目录

全球糖尿病监测设备市场规模预计将从 2023 年的 109 亿美元增加到 2030 年的 189 亿美元，预测期内复合年增长率为 8.2%。

报告范围		报告详情
基准年	2022年	2023/2024年市场规模	109亿美元
实际资料	2018-2021	预测期	2023-2030
预测期间 2023/2024 至 2030/2031 年复合年增长率：	8.20%	2030/2031价值预测	189亿美元

图 1. 2023 年糖尿病监测设备按地区分類的全球市场占有率(%)

糖尿病患者和临床医生使用血糖值监测仪来监测和控制患者的血糖值。这些设备大多数用于医院外的患者。这些患者中有许多是老年人，行动能力有限，且视力受损。血糖值仪有一个测量端口，患者将涂涂布血液的小型校准测试条插入其中进行分析。为了适应灵活性有限的用户，测试条不能太小以至于用户无法操作。

市场动态：

全球糖尿病盛行率的不断上升是推动糖尿病监测设备市场成长的主要因素。根据国际糖尿病联盟的最新资料，2021年约有5.37亿成年人患有糖尿病，预计2045年将增加至7.83亿人。糖尿病对低收入和中等收入国家的影响尤其严重，每年导致超过 120 万人死亡。全球糖尿病患者人数不断增加，健康意识不断提高，人们越来越重视有效的血糖监测和疾病管理。

然而，这个市场也面临一定的挑战。医疗保健专业人员操作复杂设备并将其纳入治疗计划的持续培训成本也导致了价格上涨。政府透过报销计画进行的有限干预进一步限制了糖尿病患者的负担能力。科技可望彻底改变糖尿病管理，但只有解决价格障碍，它的好处才能惠及大众。除非开发出替代方案，使技术创新更便宜、更容易获得，否则高价格将继续限制市场扩张，特别是在开发中地区。

儘管存在这些挑战，市场仍存在一些成长机会。新的可穿戴微创技术的发展有望彻底改变糖尿病监测。早期的例子包括连续血糖监测系统，不需要刺穿手指，并且可以佩戴长达 14 天。此外，还透过实验开发了一种贴片式感测器，可以轻鬆提取组织液。如果此类解决方案变得经济实惠且广泛可用，它们可能有助于将管理从不一致的自我记录转变为近乎持续的自动监控。这可能使糖尿病患者能够透过知情和及时的干预来更好地控制他们的疾病。

本研究的主要特点

该报告详细分析了全球糖尿病监测设备市场，并提供了以2022年为基准年的预测期（2023-2030）的市场规模和年复合成长率（CAGR%）。
它还揭示了各个细分市场的潜在商机，并为该市场说明了一系列有吸引力的投资提案。
它还提供了有关市场驱动因素、抑制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要考察。
它根据公司亮点、产品系列、主要亮点、财务表现和策略等参数，介绍了全球糖尿病监测设备市场的主要企业。
该报告的见解使行销人员和公司负责人能够就未来的产品发布、升级、市场扩张和行销策略做出明智的决策。
全球糖尿病监测设备市场报告满足该行业的各种相关人员，例如投资者、供应商、产品製造商、经销商、新进入者和财务分析师。
相关人员可以透过用于分析全球糖尿病监测设备市场的各种策略矩阵来促进他们的决策。

北美洲
美国
加拿大
欧洲
德国
英国
西班牙
法国
义大利
俄罗斯
其他欧洲国家
亚太地区
中国
印度
日本
澳洲
韩国
ASEAN
其他亚太地区
拉丁美洲
巴西
阿根廷
墨西哥
其他拉丁美洲
中东
海湾合作委员会国家
以色列
其他中东地区
非洲
南非
北非
中部非洲

第9章竞争形势

公司简介
- i-SENS, Inc.
- Ascensia Diabetes Care Holdings AG.
- Bayer AG
- Hoffmann-La Roche Ltd
- Johnson &Johnson Services, Inc.
- Medtronic
- Dexcom
- Abbott
- Labiotech UG
- ARKRAY, Inc.
- Cnoga
- Sanofi
- Lifescan
- Analysts'Views

第10章

参考
调查方法
关于出版商

简介目录

Product Code: CMI1278

Global diabetes monitoring devices market size is expected to reach US$ 18.90 Bn by 2030, from US$ 10.90 Bn in 2023, exhibiting a compound annual growth rate (CAGR) of 8.2% during the forecast period.

Report Coverage		Report Details
Base Year:	2022	Market Size in 2023/2024:	US$ 10.90 Bn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023/2024 to 2030/2031 CAGR:	8.20%	2030/2031 Value Projection:	US$ 18.90 Bn

Figure 1. Global Diabetes Monitoring Devices Market Share (%), By Region, 2023

Diabetes Monitoring Devices Market - IMG1

Blood glucose monitors are used by diabetic patients and clinicians to monitor and to help control a patient's blood glucose level. Most of these devices are used by patients outside the hospital setting. Many of these patients are elderly, with limited manual dexterity and impaired vision. Blood glucose monitors have a reading port into which patients place a small calibrated test strip, onto which they have applied blood, for analysis. In order to accommodate users with limited manual dexterity, the test strips cannot be too small by making the strip difficult for the user to handle.

Market Dynamics:

Growing prevalence of diabetes across the globe is a major factor driving the growth of diabetes monitoring devices market. According to the latest data by the International Diabetes Federation, approximately 537 million adults were living with diabetes in 2021 which is projected to rise to 783 million by 2045. Diabetes disproportionately affects lower and middle-income countries and accounts for over 1.2 million deaths each year. With the rising diabetic population worldwide and increasing health awareness, there is greater emphasis on efficient glucose monitoring and management of the disease.

However, the market also faces certain challenges. The costs involved in continuous training of healthcare providers to operate and integrate advanced devices into treatment plans also contribute to higher prices. Limited government intervention through reimbursement schemes further restrains affordability of diabetic patients. While technology holds promise to revolutionize diabetes management, its benefits can only percolate to masses if pricing obstacles are addressed. Unless alternatives are developed to make innovation more affordable and accessible, high prices will continue limiting market expansion especially in less developed regions.

Despite these challenges, the market presents several opportunities for growth. The development of novel wearable and minimally-invasive technologies is expected to transform diabetes monitoring. A few early examples include continuous glucose monitoring systems that do not require finger pricks and can be worn for up to 14 days. Patch-like sensors have also been trialed that extract interstitial fluid with little pain or hassle. If such solutions become widely accessible in an affordable way, they may help shift management from inconsistent self-tracking to near-constant automated oversight. This could help diabetics better control their condition through informed timely interventions.

Key features of the study:

This report provides in-depth analysis of the global diabetes monitoring devices market, and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global diabetes monitoring devices market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include i-SENS, Inc., Ascensia Diabetes Care Holdings AG., Bayer AG, F. Hoffmann-La Roche Ltd, Johnson & Johnson Services, Inc., Medtronic, Dexcom, Abbott, Labiotech UG, ARKRAY, Inc., Cnoga, Sanofi, and Lifescan
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global diabetes monitoring devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global diabetes monitoring devices market

Global Diabetes Monitoring Devices Market Detailed Segmentation:

By Product Type:
- Self-Monitoring Blood Glucose Devices
- Continuous Glucose Monitoring Devices
By Indication:
- Type-I Diabetes
- Type-II Diabetes
- Gestational Diabetes
By End User:
- Hospitals
- Clinics
- Ambulatory Surgical Center
- Home Care Settings
- Others
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Top Companies in the Global Diabetes Monitoring Devices Market:
- i-SENS, Inc.
- Ascensia Diabetes Care Holdings AG.
- Bayer AG
- Hoffmann-La Roche Ltd
- Johnson & Johnson Services, Inc.
- Medtronic
- Dexcom
- Abbott
- Labiotech UG
- ARKRAY, Inc.
- Cnoga
- Sanofi
- Lifescan

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By Indication
- Market Snippet, By End User
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Growing prevalence of diabetes
- Technological advancements in devices
Key Highlights
Regulatory Scenario
Recent Trends
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Mergers, Acquisitions and Collaborations

4. Global Diabetes Monitoring Devices Market- Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Diabetes Monitoring Devices Market, By Product Type, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Self-Monitoring Blood Glucose Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Continuous Glucose Monitoring Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

6. Global Diabetes Monitoring Devices Market, By Indication, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Type-I Diabetes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Type-II Diabetes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Gestational Diabetes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

7. Global Diabetes Monitoring Devices Market, By End User, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn )
Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Ambulatory Surgical Center
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

8. Global Diabetes Monitoring Devices Market, By Region, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, By Region, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Region, 2019 -2030
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
U.S.
Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
Brazil
Argentina
Mexico
Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
GCC Countries
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030, (US$ Bn)
South Africa
North Africa
Central Africa

9. Competitive Landscape

Company Profiles
- i-SENS, Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
- Ascensia Diabetes Care Holdings AG.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
- Bayer AG
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
- Hoffmann-La Roche Ltd
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
- Johnson & Johnson Services, Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
- Medtronic
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
- Dexcom
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
- Abbott
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
- Labiotech UG
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
- ARKRAY, Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
- Cnoga
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
- Sanofi
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
- Lifescan
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
- Analysts' Views

10. Section

References
Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/价格

糖尿病监测设备市场：依产品类型、按适应症、依最终用户、按地区